![](/img/cover-not-exists.png)
2620 RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis
Alekseev, B., Yang, L., Alyasova, A., Ye, D., Karpenko, A., Li, H., Xie, L., Kurteva, G., Kowalyszyn, R., Karyakin, O., Neron, Y., Cosgriff, T., Collins, L., Brechenmacher, T., Lin, J., Morgan, L., MoVolume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31438-1
Date:
September, 2015
File:
PDF, 70 KB
english, 2015